Tumor suppressor genes and medulloblastoma

Journal of Neuro-Oncology

Volumn 29, Issue 1, 1996, Pages 103-112

  Cogen, Philip H ^a   McDonald, Jeffrey D ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ABR gene; Chromosome arm 17p; Medulloblastoma; Prognostic significance; Tumor suppressor gene

Indexed keywords

CARCINOGENESIS; CHROMOSOME 17Q; CHROMOSOME DELETION; CYTOGENETICS; HUMAN; MEDULLOBLASTOMA; MOLECULAR GENETICS; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE;

CEREBELLAR NEOPLASMS; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HUMANS; MEDULLOBLASTOMA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SURVIVAL RATE;

EID: 0029944362     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00165523     Document Type: Review

References (40)

1. Belza MG, Donaldson SS, Steinberg GK: Medulloblastoma: freedom from relapse longer than 8 years - a therapeutic cure? JNS 75: 575-582, 1991
2. Friend SH, Dryja TP, Weinberg RA: Oncogenes and tumor-suppressing genes. NEJM 318: 618-622, 1988
3. Griffen CA, Hawkins AL, Packer RJ: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48: 175-180, 1988
4. Bigner SH, Friedman HS, Biegel JA: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91-101, 1988
5. Thomas GA, Raffel C: Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51: 639-643, 1991
6. Cogen PH, Daneshvar L, Metzger AK: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279-285, 1990
7. Biegel JA, Burk CD, Barr FG: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52: 3391-3395, 1992
8. James CD, He J, Carlbom E: Loss of genetic information in central nervous system tumors common to children and young adults. Genes, Chrom, Cancer 2: 1990
9. McDonald J, Daneshvar L, Willert JR: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229-232, 1994
10. Knudsen AJ Jr: Mutation and cancer: Statistical study of retinoblastoma. PNAS 68: 820-823, 1971
11. Sparkes RS, Sparkes MC, Wilson MG: Regional assignment of genes for esterase D and retinoblastoma to chromosome band 13q14. Sci 208: 1042-1044, 1980
12. Cavenee WK, Dryja TP, Phillips NA: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983
13. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, 1989
14. Friend SH, Bernards S, Rogelj S: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 313: 101-106,1985
15. Lee W-H, Shew J-Y, Hong FD: Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Nature 329: 642-645, 1987
16. Harbour JW, Lai S-L, Whang-Peng J: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Sci 241: 353-357, 1988
17. Call KM, Glaser T, Ito C: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990
18. Kinzler KW, Nilbert MC, Vogelstein B: Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Sci 251: 1366-1371, 1991
19. Marchuk DA, Saulino AM, Tavvakol R: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF gene product. Genomics 11: 931-940, 1991
20. Rouleau GA, Merel P, Lutchman M: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-522, 1993
21. Miki Y, Swensen J, Shattuck-Eidens D: A strong candicate for the breast and ovarian cancer susceptibility gene BRCA1. Sci 266: 66-72, 1994
22. Kamb A, Gruis NA, Weaver-Feldhaus J: A cell cycle regulator potentially involved in genesis of many tumor types. Sci 264: 436-440, 1994
23. Soussi T, de Fromentel CC, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogenes 5: 945-952, 1990
24. Lamb P, Crawford L: Characterization of the human p53 gene. Mol Cell Biol 6: 1379-1385, 1986
25. Baker SJ, Fearon ER, Nigro JM: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Sci 244: 217-221, 1989
26. Nigro JM, Baker SJ, Preisinger AC: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989
27. Metzger AK, Sheffield VC, Duyk G: Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. PNAS 88: 7825-7829, 1991
28. Sidransky D, Mikkelsen T, Schwechheimer K: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846-847, 1992
29. Hollstein M, Sidransky D, Vogelstein B: p53 mutations in human cancers. Sci 253: 49-54, 1991
30. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes, Chrom, Cancer 10: 221-230, 1994
31. Cogen PH, Daneshvar L, Metzger AK: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 50: 584-589, 1992
32. Sheffield VC, Cox DR, Lerman LS: Attachment of a 40-base-pair G + C-rich sequence (GC clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base-pair changes. PNAS 86: 232-236, 1989
33. Saylors RL, Sidransky D, Friedman HS: Infrequent p53 mutations in medulloblastoma. Cancer Res 51: 4721-4723, 1991
34. Adesina A, Nalbantoglu J, Cavenee WK: p53 mutation and MDM2 gene amplification are uncommon in medulloblastoma. Cancer Res 51: 5649-5651, 1994
35. Ohgaki H, Eibl RH, Wiestler D: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202-6205, 1991
36. Coles C, Thompson AM, Elder PA: Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 336: 761-763, 1990
37. DiSilvestre D, Morris C, Heisterkamp N: A second hypervariable RFLP within the ABR gene. Nucl Acids Res 18: 5925, 1990
38. Seeger RC: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. NEJM 313: 1111-1116, 1985
39. Kopelson G, Linggold RM, Kleinman GM: Medulloblastoma: The identification of prognostic subgroups and implications of multimodality management. Cancer 51: 312-320, 1983
40. Cogen PH: Prognostic signifcance of molecular genetic markers in childhood brain tumors. Fed Neurosurg 17: 245-250, 1991-1992